Econ Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.47M Buy
185,641
+37,881
+26% +$991K 2.09% 13
2026
Q1
$4.15M Buy
147,760
+122,170
+477% +$3.25M 1.93% 19
2025
Q4
$637K Buy
+25,590
New +$645K 0.32% 65
2022
Q2
Sell
-493
Closed -$26K 132
2022
Q1
$26K Sell
493
-40
-8% -$2.08K 0.02% 81
2021
Q4
$31K Buy
+533
New +$26.4K 0.02% 102

Other funds holding PFE

Econ Financial Services's PFE Position: Q2 2026 in Review

Econ Financial Services increased its Pfizer (PFE) stake by 26% in Q2 2026, buying an estimated $991K and bringing the position to 185,641 shares worth $4.47M. The position accounts for 2.09% of the portfolio, ranked #13.

Econ Financial Services first reported a position in PFE in Q4 2021 and has held it in 5 quarters since. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Econ Financial Services held 185,641 shares of Pfizer worth $4.47M as of Q2 2026.
  • Econ Financial Services bought 37,881 Pfizer shares in Q2 2026, an estimated $991K.
  • Pfizer made up 2.09% of Econ Financial Services's portfolio in Q2 2026, its #13 holding.
  • Econ Financial Services first reported a position in Pfizer in Q4 2021 and has held it in 5 quarters since.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Econ Financial Services's 13F filing for Q2 2026, filed 23 Jul 2026.